经尿道等离子电切与经尿道普通电切治疗良性前列腺增生的临床观察

Clinical studies of bipolar transurethral plasmaKinetic prostatectomy and transurethral resection of prostate for benign prostatic hyperplasia

目的探讨经尿道前列腺等离子双极电切术（TUPKP）与经尿道前列腺电切术（TuRP）治疗良性前列腺增生（BPH）的有效性及安全性。方法比较两组手术时间、术中出血量、并发症发生率、术后国际前列腺症状评分（I-PSS）、生活质量评分（QOL）、残余尿量。结果TUPKP组手术时间、术中出血量、电切综合征（TUNS）发生率、尿道狭窄发生率分别为（59±19）min、（145±35）ml、0％、2．9％；TURP组分别为（76±23）min、（295±58）ml、7．8％、5．5％，组间比较均有显著性差异（P〈0．05）。TUPKP组术后I-PSS、QOL、残余尿量分别为（5．7±1．1）、（1．1±0．8）、（20±5）ml；TURP组分别为（5．8±1．0）、（1．0±0．7）、（22±5）ml，组间比较均无显著性差异（P〉0．05），但同组与术前相比均有显著性差异（P〈0．05）。结论TUPKP与TURP对治疗BPH疗效相似，但并发症更少，手术更安全，具有良好的应用前景。

Objective To discuss the clinical efficacy and sefety of bipolar transurethral plasmaKinetic prostatectomy and transurethral resection of prostate for-benign prostatic hyperplasia. Methods BPH patients who were treated by TUPKP or TURP were reviewed and researched in operative time,intraoperative bleeding,rates of complication, the international prostate symptom score, quality of life and remnant of urine. Results In TUPKP group, operative time, intraoperative bleeding, rates of TURS and narrow urethra were （ 59 ±19 ） min, （145 ±35） ml,0% ,2. 9% ;while in TURP group,these parameters were（76 ±23）min, （295 ±58） ml,7. 8%, 5.5% ; there were significant differences between 2 groups（ P 〈 0.05 ）. In TUPKP group, the international prostate symptom score, quality of life and remnant of urine were （ 5.7 ± 1.1 ）, （ 1.1 ± 0. 8 ）, （ 20 ± 5 ） ml ; while in TURP group, these parameters were （ 5.8 ± 1.0 ）, （ 1.0 ± 0. 7 ）, （ 22 ± 5 ） ml; there were no significant difference between 2 groups（P 〉 0. 05 ）. Conclusion TUPKP and TURP have the same clinical efficacy and.sefety for the BPH patients,TUPKP has the advantages of higher safety and less complications.